Product

EPX-100

Aliases

Clemizole, Clemizole HCl, Clemizole Hydrochloride, EPX-100 (Clemizole HCl), Placebo (1 other aliases)

2 clinical trials

2 indications

Indication

Lennox-Gastaut syndrome

Indication

Dravet syndrome

Clinical trial

A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox-Gastaut Syndrome

Status: Not yet recruiting, Estimated PCD: 2025-02-01

Clinical trial

A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants With Dravet Syndrome (ARGUS Trial)

Status: Recruiting, Estimated PCD: 2024-12-19